In 2015, neurological disorders constituted about 6.3% of the global burden of disease, among which more than half of the burden in DALYs (disability-adjusted life years) was contributed by cerebrovascular disease, 12% by Alzheimer’s and other dementias, and 8% each by epilepsy and migraine, according to the WHO. The prevalence of neurological disorders and awareness of the disease and its treatment are responsible for driving the significance of brain health devices.
The rise in traumatic brain injury (TBI), stroke, and cardiac procedures are the key factors increasing the demand for brain health devices. EEG, MEG, MRI, CT scan, transcranial Doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, and other devices are widely used to monitor brain activity as well as to analyze anesthesia and sedative effect. Along with the increase in the geriatric population, the technological advancements taking place in devices with respect to functionality and efficiency also play an important role in the high adoption rate of novel, technically advanced monitoring devices on the market.
The report titled “Brain Health Devices Market: Growth, Future Prospects, and Competitive Analysis, 2016–2024” offers strategic insights into the overall brain health devices market, along with the market size and estimates for the duration of 2014–2024. The said research study covers an in-depth analysis of multiple market segments based on the type of product, therapeutic application, and different geographies.
The product type segment studied for analyzing the overall global brain health devices market is majorly segmented into electroencephalogram (EEG), computed tomography (CT), magnetic resonance imaging (MRI), magnetoencephalogram (MEG), transcranial doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, and others (positron emission tomography (PET) devices, sleep monitoring devices, and electromyography (EMG) devices).
The therapeutic applications studied for analyzing the overall global brain health devices market majorly include epilepsy, stroke, dementia, Parkinson’s disease, Huntington’s disease, headache disorders, traumatic brain injuries, sleep disorders, and other diseases (such as autism, schizophrenia, Williams syndrome, Landau-Kleffner syndrome, depression, attention-deficit hyperactivity disorder, dyslexia, and sickle-cell disease).
Geographically, the global brain health devices market is studied for the following regional markets:
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2014–2024. Market growth rates for the forecast period 2016–2024 are also included in this report, considering 2015 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global brain health devices market.
Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global brain health devices market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global brain health devices market. In-depth competitive environment analysis and historical (2014) market size data are also provided in the report.
Based on the type of therapeutic application, the brain health devices market is segmented as follows:
- Parkinson’s Disease
- Huntington’s Disease
- Headache Disorders
- Traumatic brain injuries
- Sleep Disorders
- Other Diseases (Autism, Schizophrenia, Williams Syndrome, Landau-Kleffner Syndrome, Depression, Attention-Deficit Hyperactivity Disorder, Dyslexia, and Sickle-cell Disease)
The brain health devices market by therapeutic application majorly consists of stroke, epilepsy, and Parkinson’s disease. Stroke dominates the brain monitoring device market, followed by epilepsy and Parkinson’s disease. According to the World Health Organization, around 15 million people suffer from stroke worldwide each year. Epilepsy is one of the most common neurological disorders observed worldwide and across all age groups. It is a recurrent seizure that causes brief episodes of involuntary movement of the entire body or part of the body. It accounts for 0.6% of the global burden of disease. It affects the economy in terms of loss of productivity, health care needs, and premature death.
Based on the type of device, the brain health monitoring devices market is segmented as follows:
- Electroencephalogram (EEG)
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Magnetoencephalogram (MEG)
- transcranial doppler (TCD) devices
- Intracranial Pressure (ICP) Monitors
- Cerebral Oximeters
- PET (Positron Emission Tomography) Equipment
- Devices for Monitoring Sleep
- Electromyography (EMG) Devices
Among the considered device types, the electroencephalogram segment dominates the brain monitoring market, as these devices are the most versatile and cost-effective. EEG is extensively used in clinics and hospitals to assess the activity of anesthesia and sedatives. It is widely used to diagnose sleep disorders, epilepsy, and encephalopathy. Intracranial pressure (ICP) monitors and cerebral oximeters are witnessing fast growth due to the rise in traumatic brain injuries and the risk of hypotension or hypoxia caused during or after surgical accidents.
For the purpose of this study, the global market for brain health devices is geographically categorized into:
- North America
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
In 2015, North America dominated the global brain health devices market due to contributing factors such as the high incidence of neurological disorders, rapid adoption of sophisticated healthcare technologies, high awareness about conditions such as epilepsy, Alzheimer’s, and Parkinson’s disease, an organized reimbursement system, and a well-developed healthcare infrastructure. Furthermore, Asia Pacific is the fastest-growing regional market, driven by factors such as a rapidly increasing geriatric population, rising awareness of neurodegenerative diseases, and improvements in healthcare infrastructure in emerging economies such as India, China, the Philippines, etc.